These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 25603487

  • 1. HER2/neu negative salivary duct carcinoma of parotid: A case with forty months recurrence free follow up.
    Gokavarapu S, Fonseca D, Puthamakula S, Reddy BP, Reddy BS, Murthy S.
    Int J Surg Case Rep; 2015; 8C():22-4. PubMed ID: 25603487
    [Abstract] [Full Text] [Related]

  • 2. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
    Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T.
    Cancer; 2005 Jun 15; 103(12):2526-33. PubMed ID: 15900577
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
    Al-Qahtani KH, Tunio MA, Bayoumi Y, Gurusamy VM, Bahamdain FA, Fatani H.
    J Otolaryngol Head Neck Surg; 2016 May 16; 45(1):32. PubMed ID: 27184361
    [Abstract] [Full Text] [Related]

  • 4. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.
    Nagao T, Gaffey TA, Visscher DW, Kay PA, Minato H, Serizawa H, Lewis JE.
    Am J Surg Pathol; 2004 Mar 16; 28(3):319-26. PubMed ID: 15104294
    [Abstract] [Full Text] [Related]

  • 5. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
    Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Erber R, Iro H, Fietkau R, Agaimy A.
    Strahlenther Onkol; 2017 Nov 16; 193(11):961-970. PubMed ID: 28828496
    [Abstract] [Full Text] [Related]

  • 6. Salivary duct carcinoma of the parotid gland.
    Mlika M, Kourda N, Zidi Y, Aloui R, Zneidi N, Rammeh S, Zermani R, Jilani SB.
    J Oral Maxillofac Pathol; 2012 Jan 16; 16(1):134-6. PubMed ID: 22434951
    [Abstract] [Full Text] [Related]

  • 7. Salivary duct carcinoma--a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression.
    Skálová A, Stárek, Kucerová V, Szépe P, Plank L.
    Pathol Res Pract; 2001 Jan 16; 197(9):621-6. PubMed ID: 11569926
    [Abstract] [Full Text] [Related]

  • 8. Salivary Duct Carcinoma with Late Distant Brain and Cutaneous Metastasis: A Case Report.
    Mirmohammad Sadeghi H, Karimi A, Rahpeima A, Derakhshan S.
    Iran J Pathol; 2020 Jan 16; 15(3):521-525. PubMed ID: 32754223
    [Abstract] [Full Text] [Related]

  • 9. Salivary duct carcinoma of the parotid gland: A case report and review of the literature.
    Xie S, Yang H, Bredell M, Shen S, Yang H, Jin L, Zhang S.
    Oncol Lett; 2015 Jan 16; 9(1):371-374. PubMed ID: 25435994
    [Abstract] [Full Text] [Related]

  • 10. Myoepithelial Carcinoma Arising in a Salivary Duct Cyst of the Parotid Gland: Case Presentation.
    Gontarz M, Orłowska-Heitzman J, Gąsiorowski K, Bargiel J, Marecik T, Szczurowski P, Zapała J, Wyszyńska-Pawelec G.
    Medicina (Kaunas); 2023 Jan 17; 59(2):. PubMed ID: 36837386
    [Abstract] [Full Text] [Related]

  • 11. Solitary adrenal metastasis from salivary duct carcinoma of the parotid gland successfully treated by surgery: A case report.
    Amano Y, Tsuji K, Kihara A, Matsubara D, Fukushima N, Nishino H, Niki T.
    Medicine (Baltimore); 2021 Jan 15; 100(2):e24011. PubMed ID: 33466142
    [Abstract] [Full Text] [Related]

  • 12. The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers.
    Hanna GJ, Bae JE, Lorch JH, Haddad RI, Jo VY, Schoenfeld JD, Margalit DN, Tishler RB, Goguen LA, Annino DJ, Chau NG.
    Oncologist; 2020 Jul 15; 25(7):598-608. PubMed ID: 32310325
    [Abstract] [Full Text] [Related]

  • 13. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
    Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A.
    Hum Pathol; 2019 Nov 15; 93():37-47. PubMed ID: 31437521
    [Abstract] [Full Text] [Related]

  • 14. HER2/HER3-positive metastatic salivary duct carcinoma in the pleural effusion: A case report.
    Murata K, Kawahara A, Ono T, Takase Y, Abe H, Naito Y, Akiba J.
    Diagn Cytopathol; 2018 May 15; 46(5):429-433. PubMed ID: 29205961
    [Abstract] [Full Text] [Related]

  • 15. Mandibular osteosclerotic lesion of a parotid salivary duct carcinoma: demonstration of the neural tropism of these tumors.
    Lazard DS, Baglin AC, Baujat B, Cox A, Condette-Auliac S, Chabolle F.
    Eur Ann Otorhinolaryngol Head Neck Dis; 2010 Nov 15; 127(5):189-92. PubMed ID: 20934935
    [Abstract] [Full Text] [Related]

  • 16. Salivary duct carcinoma: evaluation of treatment and outcome in a tertiary referral institute.
    Beck ACC, Lohuis PJFM, Al-Mamgani A, Smit LA, Klop WMC.
    Eur Arch Otorhinolaryngol; 2018 Jul 15; 275(7):1885-1892. PubMed ID: 29785551
    [Abstract] [Full Text] [Related]

  • 17. Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland.
    Cornolti G, Ungari M, Morassi ML, Facchetti F, Rossi E, Lombardi D, Nicolai P.
    Arch Otolaryngol Head Neck Surg; 2007 Oct 15; 133(10):1031-6. PubMed ID: 17938328
    [Abstract] [Full Text] [Related]

  • 18. Salivary Duct Carcinoma with Rhabdoid Features of the Parotid Gland with No E-Cadherin Expression: A Report with Anti-HER2 Therapy and Review of the Literature.
    Jain R, Sansoni ER, Angel J, Gleysteen JP, Hayes DN, Owosho AA.
    Dent J (Basel); 2023 Sep 25; 11(10):. PubMed ID: 37886914
    [Abstract] [Full Text] [Related]

  • 19. Solitary late spinal metastasis from apocrine salivary duct carcinoma: Case report.
    Baldassarre BM, Penner F, Bertero L, Di Perna G, Ajello M, Marengo N, Zenga F, Garbossa D.
    Surg Neurol Int; 2021 Sep 25; 12():122. PubMed ID: 33880227
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression.
    Berendika J, Jungić S, Tubić B, Malčić Kecman G, Rakita I, Gojković Z, Vještica M, Nikić G, Babić B.
    Case Rep Oncol; 2021 Sep 25; 14(1):610-615. PubMed ID: 33976642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.